Bulk Inquiry
ZCL 278
- Soluble in DMSO
- MF: C21H19BrClN5O4S2
- MW: 584.89
Description
Selective Cdc42 GTPase inhibitor. ZCL 278 specifically targets Cdc42–ITSN interaction and inhibits Cdc42-mediated cellular processes, thus providing a powerful tool for research of Cdc42 subclass of Rho GTPases in human pathogenesis. ZCL 278 reduces the perinuclear accumulation of active Cdc42 in contrast to NSC 23766 (Axon 1578), a selective Rac inhibitor.
More Information
| Parent CAS No. | 587841-73-4 |
|---|---|
| Chemical Name | 2-(4-bromo-2-chlorophenoxy)-N-(4-(N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl)phenylcarbamothioyl)acetamide |
| SMILES | C(NC(NC1=CC=C(S(NC2=NC(C)=CC(C)=N2)(=O)=O)C=C1)=S)(=O)COC1=CC=C(Br)C=C1Cl |
| MFCD | N.A. |
| InChi | InChI=1S/C21H19BrClN5O4S2/c1-12-9-13(2)25-20(24-12)28-34(30,31)16-6-4-15(5-7-16)26-21(33)27-19(29)11-32-18-8-3-14(22)10-17(18)23/h3-10H,11H2,1-2H3,(H,24,25,28)(H2,26,27,29,33) |
| InChiKey | XKZDWYDHEBCGCG-UHFFFAOYSA-N |
| CID | 1791111 |
| Short Description | Cdc42 Inhibitor |
Other Categories
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.


